The Access Forum is a flagship US-based event convening pharma, payers, providers, and policy experts to address the complexities of market access, pricing, and patient affordability. With a focus on current regulatory shifts and innovative contracting, it provides a high-level, practical platform for strategy-sharing and peer learning.
On Day Three, Verpora’s Omar Ali joins a distinguished panel to lead a workshop exploring the realities of Medicare Drug Price Negotiation under the latest White House administration:
Workshop
CMS Drug Price Negotiations – Reading the Redacted Room
Friday, June 10th, 2025 at 10:15 AM - 11:30 AM - Breakout Room 2
Facilitators:
Omar Ali, Head of Payers, Verpora
Ross Margulies, Legal Partner, Manatt
Drake Reiter, Director, Pharmacy Operations, Priority Health
Arijit Ganguli, President, ValueGenix Strategies LLC
This session offers a rare behind-the-scenes perspective on CMS drug pricing negotiations. Drawing on insights from last year’s MLS sessions—and anticipating key differences in the latest negotiation cycle—it explores how pharma companies are navigating ICR submissions, technical responses, and challenging secondary questions.
With Verpora and Manatt having previously collaborated on multiple IPAY cohort engagements, the session integrates legal, payer, and strategic viewpoints to help attendees understand:
Who’s in the negotiation room—and why it matters
Evolving CMS approaches under the new administration
Therapeutic alternative allocation, ceiling price setting, and initial offers
Critical timelines, policy trends, and what’s different this year
How to prepare for the unexpected in high-stakes pricing discussions
If your organisation is preparing for CMS negotiation or engaging in IRA/IPAY strategy, this is a session not to miss.
Representing Verpora
Omar Ali
BSc(Hons)Pharm, DipClinPharm, MRPharmS, ACPP
Head of Payers, Verpora & Former Adviser to NICE
More Info & Registration
More information and registration directly via the ACCESS US 2025 event website